These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31291843)

  • 1. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
    Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF; Wojdyla D; Pastor-Asurza CA; Gamboa-Cárdenas RV; Acevedo-Vásquez EM; Catoggio LJ; García MA; Bonfá E; Sato EI; Massardo L; Pascual-Ramos V; Barile LA; Reyes-Llerena G; Iglesias-Gamarra A; Molina-Restrepo JF; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2018 Apr; 27(4):536-544. PubMed ID: 28857715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
    J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Pons-Estel GJ; Soriano ER; Saurit V; Sato EI; Lavras Costallat LT; Molina JF; Iglesias-Gamarra A; Reyes-Llerena G; Neira OJ; Barile LA; Silveira LH; Segami MI; Chacón-Díaz R; Wojdyla D; Alarcón GS; Pons-Estel BA
    Semin Arthritis Rheum; 2017 Oct; 47(2):199-203. PubMed ID: 28291583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
    Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
    Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Rodríguez-Bellido Z; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Cucho-Venegas M; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2019 Oct; 28(11):1344-1349. PubMed ID: 31551028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.
    Pons-Estel GJ; Alarcón GS; Burgos PI; Hachuel L; Boggio G; Wojdyla D; Nieto R; Alvarellos A; Catoggio LJ; Guibert-Toledano M; Sarano J; Massardo L; Vásquez GM; Iglesias-Gamarra A; Lavras Costallat LT; Da Silva NA; Alfaro JL; Abadi I; Segami MI; Huerta G; Cardiel MH; Pons-Estel BA;
    Lupus; 2013 Aug; 22(9):899-907. PubMed ID: 23857989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of non-renal non-neurologic persistent lupus activity in real world patients from Argentina.
    Scolnik M; Scaglioni V; Pons-Estel GJ; Soriano ER
    Lupus; 2019 Aug; 28(9):1167-1173. PubMed ID: 31299882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Catoggio LJ; Drenkard C; Sarano J; Berbotto GA; Borba EF; Sato EI; Tavares Brenol JC; Uribe O; Ramirez Gómez LA; Guibert-Toledano M; Massardo L; Cardiel MH; Silveira LH; Chacón-Diaz R; Alarcón GS; Pons-Estel BA;
    Ann Rheum Dis; 2017 Dec; 76(12):2071-2074. PubMed ID: 28939626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
    Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
    Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.
    Ruiz-Arruza I; Lozano J; Cabezas-Rodriguez I; Medina JA; Ugarte A; Erdozain JG; Ruiz-Irastorza G
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):582-591. PubMed ID: 28704598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF; Acevedo-Vásquez E; Alarcón GS; Pastor-Asurza CA; Alfaro-Lozano JL; Cucho-Venegas JM; Segami MI; Wojdyla D; Soriano ER; Drenkard C; Brenol JC; de Oliveira e Silva Montandon AC; Costallat LT; Massardo L; Molina-Restrepo JF; Guibert-Toledano M; Silveira LH; Amigo MC; Barile-Fabris LA; Chacón-Díaz R; Esteva-Spinetti MH; Pons-Estel GJ; McGwin G; Pons-Estel BA;
    Ann Rheum Dis; 2015 Jun; 74(6):1019-23. PubMed ID: 24525909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
    Reátegui-Sokolova C; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Serrano-Morales RM; Sacnun MP; Catoggio LJ; Soriano ER; García MA; Saurit V; Alvarellos A; Caeiro F; Berbotto GA; Sato EI; Borba Neto EF; Bonfa E; de Oliveira E Silva Montandon AC; Da Silva NA; Cavalcanti F; Vásquez G; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Portela-Hernández M; Garcia de la Torre I; Segami MI; Chacón-Diaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA;
    RMD Open; 2020 Dec; 6(3):. PubMed ID: 33310863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
    Ruiz-Arruza I; Ugarte A; Cabezas-Rodriguez I; Medina JA; Moran MA; Ruiz-Irastorza G
    Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
    Zeña-Huancas PA; Iparraguirre-López H; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Zevallos-Miranda F; Medina-Chinchon M; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Sarmiento-Velasquez O; Cucho-Venegas JM; Alfaro-Lozano JL; Rodríguez-Bellido ZJ; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
    Clin Rheumatol; 2019 Apr; 38(4):1139-1146. PubMed ID: 30539353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
    Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
    Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
    Ruiz-Arruza I; Barbosa C; Ugarte A; Ruiz-Irastorza G
    Autoimmun Rev; 2015 Oct; 14(10):875-9. PubMed ID: 26044819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF; Hanly J; Urowitz M; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Pons-Estel BA; Alarcón GS
    Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.